title: Perindopril (Coversyl) prevents cardiovascular death and MI in coronary disease patients regardless of their cardiovascular risk.
authors.affiliation: Hatter Institute, Cape Heart Centre, University of Cape Town Medical School, Cape Town, South Africa.
authors.forename: Lionel
authors.initials: L
authors.lastname: Opie
authors.forename: Tony
authors.initials: T
authors.lastname: Dalby
authors.forename: D P
authors.initials: DP
authors.lastname: Naidoo
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000188:drug therapy*; D003643:Death; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D020913:Perindopril / Q000008:administration & dosage*; D012307:Risk Factors
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D020913:Perindopril